Orbimed Advisors as of Dec. 31, 2019
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 135 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 6.6 | $465M | 3.3M | 139.12 | |
Synthorx | 5.3 | $372M | 5.3M | 69.89 | |
Tricida | 5.2 | $363M | 9.6M | 37.74 | |
Springworks Therapeutics (SWTX) | 4.1 | $285M | 7.4M | 38.49 | |
Prevail Therapeutics Ord | 3.1 | $219M | 14M | 15.83 | |
Boston Scientific Corporation (BSX) | 3.0 | $211M | 4.7M | 45.22 | |
Alector (ALEC) | 2.7 | $189M | 11M | 17.23 | |
Alexion Pharmaceuticals | 2.6 | $180M | 1.7M | 108.15 | |
Merck & Co (MRK) | 2.5 | $178M | 2.0M | 90.95 | |
Mirati Therapeutics | 2.5 | $173M | 1.3M | 128.86 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $172M | 783k | 218.95 | |
Turning Point Therapeutics I | 2.4 | $171M | 2.7M | 62.29 | |
Iovance Biotherapeutics (IOVA) | 2.2 | $154M | 5.5M | 27.68 | |
Nextcure (NXTC) | 2.2 | $153M | 2.7M | 56.33 | |
Humana (HUM) | 2.0 | $144M | 392k | 366.52 | |
Bristol Myers Squibb (BMY) | 1.6 | $109M | 1.7M | 64.19 | |
eHealth (EHTH) | 1.5 | $107M | 1.1M | 96.08 | |
89bio (ETNB) | 1.5 | $105M | 4.0M | 26.29 | |
Edwards Lifesciences (EW) | 1.4 | $102M | 435k | 233.29 | |
Neurocrine Biosciences (NBIX) | 1.4 | $101M | 936k | 107.49 | |
Inspire Med Sys (INSP) | 1.4 | $100M | 1.3M | 74.21 | |
Cigna Corp (CI) | 1.4 | $100M | 490k | 204.49 | |
Intuitive Surgical (ISRG) | 1.4 | $99M | 168k | 591.15 | |
ArQule | 1.4 | $100M | 5.0M | 19.96 | |
Sarepta Therapeutics (SRPT) | 1.4 | $99M | 766k | 129.04 | |
Danaher Corporation (DHR) | 1.4 | $98M | 639k | 153.48 | |
Bausch Health Companies (BHC) | 1.4 | $95M | 3.2M | 29.92 | |
Deciphera Pharmaceuticals | 1.4 | $94M | 1.5M | 62.24 | |
Glaukos (GKOS) | 1.2 | $84M | 1.5M | 54.47 | |
Ptc Therapeutics I (PTCT) | 1.2 | $83M | 1.7M | 48.03 | |
Natera (NTRA) | 1.2 | $82M | 2.4M | 33.69 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $79M | 209k | 375.48 | |
Uniqure Nv (QURE) | 1.1 | $78M | 1.1M | 71.66 | |
Arvinas Ord (ARVN) | 1.1 | $78M | 1.9M | 41.09 | |
Thermo Fisher Scientific (TMO) | 1.0 | $72M | 221k | 324.87 | |
Meiragtx Holdings (MGTX) | 1.0 | $69M | 3.5M | 20.02 | |
Tandem Diabetes Care (TNDM) | 1.0 | $68M | 1.1M | 59.61 | |
Exelixis (EXEL) | 0.9 | $66M | 3.8M | 17.62 | |
Abbott Laboratories (ABT) | 0.9 | $62M | 715k | 86.86 | |
Horizon Therapeutics | 0.8 | $57M | 1.6M | 36.20 | |
Krystal Biotech (KRYS) | 0.8 | $55M | 995k | 55.38 | |
Bellus Health | 0.8 | $53M | 7.0M | 7.56 | |
Dex (DXCM) | 0.7 | $51M | 235k | 218.74 | |
Crinetics Pharmaceuticals In (CRNX) | 0.7 | $51M | 2.0M | 25.09 | |
Adverum Biotechnologies | 0.7 | $50M | 4.3M | 11.52 | |
Aurinia Pharmaceuticals (AUPH) | 0.7 | $48M | 2.3M | 20.26 | |
Crispr Therapeutics (CRSP) | 0.7 | $47M | 766k | 60.90 | |
Prothena (PRTA) | 0.7 | $46M | 2.9M | 15.83 | |
Logicbio Therapeutics | 0.7 | $47M | 6.5M | 7.20 | |
Athenex | 0.6 | $42M | 2.8M | 15.27 | |
Argenx Se (ARGX) | 0.6 | $41M | 256k | 160.52 | |
Tela Bio (TELA) | 0.6 | $39M | 3.0M | 12.95 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $37M | 6.8M | 5.44 | |
Harpoon Therapeutics | 0.5 | $36M | 2.4M | 14.79 | |
Anthem (ELV) | 0.5 | $32M | 107k | 302.03 | |
Amgen (AMGN) | 0.4 | $29M | 122k | 241.07 | |
Hca Holdings (HCA) | 0.4 | $28M | 190k | 147.81 | |
Iqvia Holdings (IQV) | 0.4 | $27M | 175k | 154.51 | |
Zimmer Holdings (ZBH) | 0.4 | $27M | 179k | 149.68 | |
Applied Therapeutics (APLT) | 0.4 | $27M | 987k | 27.28 | |
Verrica Pharmaceuticals (VRCA) | 0.3 | $24M | 1.5M | 15.89 | |
SPDR S&P Biotech (XBI) | 0.3 | $23M | 237k | 95.11 | |
Chardan Healthcare Acqu- Ord | 0.3 | $22M | 2.3M | 9.68 | |
Aeglea Biotherapeutics | 0.3 | $22M | 2.9M | 7.64 | |
Zai Lab (ZLAB) | 0.3 | $21M | 514k | 41.59 | |
Gilead Sciences (GILD) | 0.3 | $21M | 326k | 64.98 | |
Scpharmaceuticals (SCPH) | 0.3 | $19M | 3.4M | 5.66 | |
Alcon (ALC) | 0.3 | $20M | 351k | 56.70 | |
Biogen Idec (BIIB) | 0.3 | $19M | 65k | 296.73 | |
Novo Nordisk A/S (NVO) | 0.3 | $19M | 330k | 57.88 | |
Avantor (AVTR) | 0.3 | $18M | 1.0M | 18.15 | |
Sinovac Biotech | 0.2 | $17M | 2.8M | 6.04 | |
Xtant Med Hldgs (XTNT) | 0.2 | $15M | 9.2M | 1.60 | |
Alpine Immune Sciences | 0.2 | $14M | 3.7M | 3.84 | |
Kala Pharmaceuticals | 0.2 | $13M | 3.4M | 3.69 | |
Avrobio Ord (AVRO) | 0.2 | $13M | 635k | 20.13 | |
Karyopharm Therapeutics (KPTI) | 0.2 | $12M | 622k | 19.17 | |
Mersana Therapeutics (MRSN) | 0.2 | $12M | 2.1M | 5.73 | |
X4 Pharmaceuticals (XFOR) | 0.2 | $12M | 1.1M | 10.70 | |
Health Care SPDR (XLV) | 0.2 | $12M | 113k | 101.86 | |
Neoleukin Therapeutics | 0.2 | $11M | 900k | 12.32 | |
Obseva Sa | 0.1 | $10M | 2.6M | 3.82 | |
Foamix Pharmaceuticals | 0.1 | $8.6M | 2.6M | 3.33 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $8.3M | 635k | 13.11 | |
Essa Pharma (EPIX) | 0.1 | $8.1M | 1.5M | 5.50 | |
Iveric Bio | 0.1 | $8.6M | 1.0M | 8.58 | |
Cti Biopharma | 0.1 | $7.9M | 5.0M | 1.58 | |
Pfenex | 0.1 | $6.8M | 615k | 10.98 | |
Selecta Biosciences | 0.1 | $6.9M | 2.9M | 2.38 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $7.2M | 1.3M | 5.75 | |
Restorbio | 0.1 | $7.2M | 4.8M | 1.49 | |
Aptose Biosciences | 0.1 | $6.5M | 1.2M | 5.67 | |
Zogenix | 0.1 | $6.5M | 125k | 52.13 | |
Ionis Pharmaceuticals (IONS) | 0.1 | $6.5M | 107k | 60.41 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $6.1M | 376k | 16.25 | |
Nabriva Therapeutics | 0.1 | $6.1M | 4.6M | 1.32 | |
Health Catalyst (HCAT) | 0.1 | $6.2M | 180k | 34.70 | |
Amarin Corporation (AMRN) | 0.1 | $5.4M | 250k | 21.44 | |
AtriCure (ATRC) | 0.1 | $5.5M | 169k | 32.51 | |
Acceleron Pharma | 0.1 | $5.7M | 108k | 53.02 | |
Personalis Ord (PSNL) | 0.1 | $5.3M | 484k | 10.90 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $5.8M | 364k | 16.01 | |
Incyte Corporation (INCY) | 0.1 | $5.2M | 60k | 87.33 | |
Arena Pharmaceuticals | 0.1 | $5.0M | 110k | 45.42 | |
Synlogic | 0.1 | $5.2M | 2.0M | 2.58 | |
ACADIA Pharmaceuticals (ACAD) | 0.1 | $4.1M | 96k | 42.78 | |
AstraZeneca (AZN) | 0.1 | $3.5M | 70k | 49.86 | |
Sanofi-Aventis SA (SNY) | 0.1 | $3.4M | 68k | 50.20 | |
Dermira | 0.1 | $3.8M | 250k | 15.16 | |
Intellia Therapeutics (NTLA) | 0.1 | $3.8M | 262k | 14.67 | |
Aerpio Pharmaceuticals | 0.1 | $3.2M | 5.2M | 0.62 | |
BioMarin Pharmaceutical (BMRN) | 0.0 | $2.9M | 35k | 84.55 | |
Intercept Pharmaceuticals In | 0.0 | $2.8M | 23k | 123.90 | |
Flexion Therapeutics | 0.0 | $2.8M | 133k | 20.70 | |
Kalvista Pharmaceuticals (KALV) | 0.0 | $2.9M | 161k | 17.81 | |
Myokardia | 0.0 | $2.0M | 28k | 72.87 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $1.9M | 212k | 8.78 | |
Novus Therapeutics | 0.0 | $1.8M | 3.2M | 0.58 | |
Curis | 0.0 | $2.3M | 1.4M | 1.70 | |
ImmunoGen | 0.0 | $1.5M | 287k | 5.10 | |
Insmed (INSM) | 0.0 | $1.4M | 59k | 23.88 | |
Otonomy | 0.0 | $1.3M | 351k | 3.83 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $1.6M | 1.4M | 1.20 | |
Regenxbio Inc equity us cm (RGNX) | 0.0 | $1.1M | 27k | 40.97 | |
Protagonist Therapeutics (PTGX) | 0.0 | $1.3M | 191k | 7.05 | |
Spero Therapeutics (SPRO) | 0.0 | $1.3M | 132k | 9.62 | |
Sutro Biopharma (STRO) | 0.0 | $1.2M | 105k | 11.00 | |
Mirum Pharmaceuticals (MIRM) | 0.0 | $1.7M | 71k | 24.52 | |
Rts/bristol-myers Squibb Compa | 0.0 | $1.1M | 350k | 3.01 | |
Zafgen | 0.0 | $911k | 821k | 1.11 | |
Mustang Bio | 0.0 | $1.0M | 252k | 4.08 | |
Aptinyx | 0.0 | $489k | 143k | 3.42 | |
Rubius Therapeutics | 0.0 | $950k | 100k | 9.50 | |
Medigus | 0.0 | $26k | 15k | 1.73 | |
Biolinerx (BLRX) | 0.0 | $156k | 69k | 2.25 |